MPO’s Most-Read Stories This Week—July 8

Money and new products/technology drove MPO website traffic this past holiday week. 

The most tantalizing by far was the report of three startups from the BioInnovation Institute joining a customized accelerator program that helps early-stage companies build their U.S. go-to-market strategy. The specialized accelerator is modeled and builds off the success of the Texas Medical Center Innovation Health Tech Accelerator program.

Other new technology bytes that captivated cybervisitors included the Health Canada approval of Dexcom’s next-gen Dexcom G7 continuous glucose monitoring system and the FDA approval of U.S. Medical Innovations’ Canady Flex RoboWrist robotic surgery device for open and laparoscopic surgeries.

Pageview-propelling financials news came courtesy of Avertix’s merger with BIOS Acquisition Corporation, and Magenta Medical’s most recent funding round.

1. Danish Startups Pursue U.S. Expansion Opportunities Through TMC BioBridge

2. Dexcom G7 CGM Earns Health Canada Approval

3. Avertix Merges With BIOS Acquisition Corporation

4. Magenta Medical Closes $55 Million Funding Round

5. USMI’s Flex RoboWrist Surgical Instrument Gains FDA Nod